A study assessing one year outcomes after switching from a bivalirudin-first strategy to a heparin first strategy for all percutaneous coronary interventions in a single-center cardiac catheterization lab.

Trial Profile

A study assessing one year outcomes after switching from a bivalirudin-first strategy to a heparin first strategy for all percutaneous coronary interventions in a single-center cardiac catheterization lab.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Oct 2016

At a glance

  • Drugs Bivalirudin (Primary) ; Heparin (Primary)
  • Indications Acute coronary syndromes; Thrombosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 08 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top